Groowe Groowe / Newsroom / REGN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

REGN News

Regeneron Pharmaceuticals Inc

REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

accessnewswire.com
REGN

Class Action Alert: Levi & Korsinsky Reminds Regeneron (REGN) Investors of September 14, 2026 Deadline

accessnewswire.com
REGN

REGN ALERT: Securities Fraud Class Action Launched Against Regeneron Pharmaceuticals, Inc. - September 14, 2026 Deadline

accessnewswire.com
REGN

Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit – Hagens Berman

globenewswire.com
REGN

Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit – Hagens Berman

globenewswire.com
REGN

Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Regeneron Pharmaceuticals, Inc. – REGN

accessnewswire.com
REGN

Motorcycle Tires Market to Reach USD 26.94 Billion by 2035, Driven by Asia-Pacific Two-Wheeler Production and Electric Mobility Growth, Reports Radial Insights

prnewswire.com
TSEM CC GOOG MSFT NVDA AMZN META IBM INTC AMD QCOM MU ADI TXN AVGO MRVL SNPS CDNS AMAT LRCX KLAC ASML CRDO PLTR DDOG SNOW CRM ADBE PANW ZS FTNT CRWD MCHP ON NXPI STM ELF ALGN EXAS REGN GILD BIIB VRTX AMGN BMY PFE MRNA ABBV LULU COST WMT HD MCD CMG SBUX TSLA NIO RIVN LCID GM F STLA VWAGY HOG HON GE BA LMT RTX GD NOC XOM CVX SHEL T VZ TMUS CMCSA NFLX DIS KO PEP MDT ABT JNJ SPG PLD AMT EQIX CCI O SPGI MS GS JPM BAC WFC C AXP V MA PYPL COIN GOOGL

Class Action Lawsuit Filed: Regeneron Pharmaceuticals, Inc. (REGN) - Join by September 14, 2026 - Contact Levi & Korsinsky

accessnewswire.com
REGN

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
REGN

REGN ALERT: Securities Fraud Class Action Launched Against Regeneron Pharmaceuticals, Inc. - September 14, 2026 Deadline

accessnewswire.com
REGN